112 (Januvia 50 mg)
Generic Name: sitagliptin
Pill imprint 112 has been identified as Januvia 50 mg.
Januvia is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 50 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 112 (Januvia 50 mg)
Januvia
- Generic Name:
- sitagliptin
- Imprint:
-
112
- Strength:
- 50 mg
- Color:
- Beige
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Merck & Company Inc.
- National Drug Code (NDC):
- 00006-0112
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferric oxide yellow
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-6031 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More resources
Januvia is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
